Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 239-269-6 | CAS number: 15217-42-2
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
No study available. The relevant physico-chemical data are assessed in regard of toxicokinetics. (Assessment of the toxicokinetic behaviour of the substance to the extent that can be derived from the relevant available information, EC 2006/1907, Annex VII, 8.8.1)
Key value for chemical safety assessment
- Bioaccumulation potential:
- low bioaccumulation potential
- Absorption rate - oral (%):
- 100
- Absorption rate - dermal (%):
- 100
- Absorption rate - inhalation (%):
- 10
Additional information
There is one study available for the structural analogue 1H-Benzotriazole on the metabolism. However, this study does not give sufficient information for this endpoint and is regarded as supporting study.
Physicochemical parameters used for toxicokinetic Endpoint summary:
Parameter |
Value used for CSR |
Molecular weight |
141.11 g/mol |
Melting point |
Decomposition at 245 °C |
Boiling point |
Decomposition at 245 °C |
Density |
1.42 g/cm3(at 15 °C) |
Vapour pressure |
0.001 Pa (at 20 °C) |
Partition coefficient n-octanol/water (log POW) |
0.480 (at 25 °C) |
Water solubility |
> 10 g/L (at 25 °C) / 49.9 % w/w |
pH |
ca. 12 |
pKa |
8.57 (at 25 °C) |
Particle size |
The substance is manufactured and marketed as aqueous solution |
Based on these parameters, the bioaccumulation potential is judged as low (log POW< 4).
The pure substance is a solid with a low vapour pressure. It is manufactured and marketed as an aqueous solution. Based on this information the inhalative absorption is assumed to be 10 %. For dermal and oral Absorption rate 100 % are assumed by default.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
